SCHEMBL7049065

SCHEMBL7049065

Cc1ccc(S(=O)(=O)Oc2cc(C(=O)Cc3ccccc3)cc([N+](=O)[O-])c2OS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.43
HTT P42858 3/20 0.40
MAPT P10636 3/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40
KMT2A Q03164 5/20 0.39
MEN1 O00255 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GPR17 Q13304 1/20 0.39
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
LMNA P02545 3/20 0.38
MAPK1 P28482 3/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7048480 0.75 TOP1 (0.42) ALDH1A1MAPTCYP3A4KMT2AMEN1
SCHEMBL7046037 0.73 NPC1 (0.43) ALDH1A1MAPTCYP2C19CYP3A4KMT2A
SCHEMBL13167860 0.73 TSHR (0.54) ALDH1A1MAPTKMT2AMEN1GPR17
SCHEMBL7048078 0.72 TTR (0.52) ALDH1A1MAPTCYP3A4KMT2AMEN1
SCHEMBL7049743 0.72 BCL9 (0.41) ALDH1A1HTTMAPTKMT2AMEN1
SCHEMBL660755 0.71 ALDH1A1 (0.53) ALDH1A1HTTMAPTKMT2AMEN1
SCHEMBL8620905 0.70 MEN1 (0.43) ALDH1A1HTTMAPTKMT2AMEN1
SCHEMBL4293802 0.69 NPC1 (0.65) ALDH1A1HTTMAPTCYP3A4KMT2A
SCHEMBL27619877 0.69 RECQL (0.52) ALDH1A1HTTMAPTCYP3A4KMT2A
SCHEMBL9007689 0.69 PAX8 (0.49) ALDH1A1HTTMAPTCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1010688-B1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them PORTELA & CA SA (PT) 2003-04-09 EP disclosed
US-6512136-B1 Hypotensive, antiedemic agents; gastrointestinal disorders; Parkinson*s disease treatment PORTELA & C.A., S.A. (PT) 2003-01-28 US disclosed
EP-1010688-A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them Portela & Ca., S.A. (PT) 2000-06-21 EP disclosed